University halts Vical studies

Documents released today at the Recombinant DNA Advisory Committee meeting in Washington revealed that the Institutional Biosafety Committee (IBC) at the University of South Florida has halted its trials of Vical's Allovectin-7 gene therapy for cancer. The decision to halt the

Read the full 414 word article

How to gain access

Continue reading with a
two-week free trial.